Characterization of fusion partner genes in 114 patients with de novo acute myeloid leukemia and MLL rearrangement (original) (raw)

• Ziemin-van der Poel S, McCabe NR, Gill HJ, Espinosa III R, Patel Y, Harden A et al. Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias. Proc Natl Acad Sci USA 1991; 88: 10735–10739.
  Article CAS PubMed PubMed Central Google Scholar
• Bernard OA, Berger R . Molecular basis of 11q23 rearrangements in hematopoietic malignant proliferations. Genes Chromosomes Cancer 1995; 13: 75–85.
  Article CAS PubMed Google Scholar
• Marschalek R . MLL (myeloid/lymphoid or mixed lineage leukemia). Atlas Genet Cytogenet Oncol Haematol. November 2002. Available at: http://www.infobiogen.fr/services/chromcancer/Genes/MLL.html.
• Meyer C, Schneider B, Reichel M, Angermueller S, Strehl S, Schnittger S et al. Diagnostic tool for the identification of MLL rearrangements including unknown partner genes. Proc Natl Acad Sci USA 2005; 102: 449–454.
  Article CAS PubMed Google Scholar
• Thirman MJ, Gill JH, Burnett RC, Mbangkollo D, McCabe NR, Kobayashi H et al. Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations. N Engl J Med 1993; 329: 909–914.
  Article CAS PubMed Google Scholar
• Swansbury GJ, Slater R, Bain BJ, Moorman AV, Secker-Walker LM . Hematological malignancies with t(9;11)(p21–22;q23): a laboratory and clinical study of 125 cases. Leukemia 1998; 12: 792–800.
  Article CAS PubMed Google Scholar
• Iida S, Seto M, Yamamoto K, Komatsu H, Tojo A, Asano S et al. _MLL_T3 gene on 9p22 involved in t(9;11) leukemia encodes a serine/proline rich protein homologous to _MLL_T1 on 19p13. Oncogene 1993; 8: 3085–3092.
  CAS PubMed Google Scholar
• Martineau M, Berger R, Lillington DM, Moorman AV, Secker-Walker LM . The t(6;11)(q27;q23) translocation in acute leukemia: a laboratory and clinical study of 30 cases. Leukemia 1998; 12: 788–791.
  Article CAS PubMed Google Scholar
• Lillington DM, Young BD, Berger R, Martineau M, Moorman AV, Secker-Walker LM . The t(10;11)(p12;q23) translocation in acute leukaemia: a cytogenetic and clinical study of 20 patients. European 11q23 Workshop participants. Leukemia 1998; 12: 801–804.
  Article CAS PubMed Google Scholar
• Moorman AV, Hagemeijer A, Charrin C, Rieder H, Secker-Walker LM . The translocations, t(11;19)(q23;p13.1) and t(11;19)(q23;p13.3): a cytogenetic and clinical profile of 53 patients. Leukemia 1998; 12: 805–810.
  Article CAS PubMed Google Scholar
• Prasad R, Gu Y, Alder H, Nakamura T, Canaani O, Saito H et al. Cloning of the ALL-1 fusion partner, the AF-6 gene, involved in acute myeloid leukemias with the t(6;11) chromosome translocation. Cancer Res 1993; 53: 5624–5628.
  CAS PubMed Google Scholar
• Chaplin T, Bernard O, Beverloo HB, Saha V, Hagemeijer A, Berger R et al. The t(10;11) translocation in acute myeloid leukemia (M5) consistently fuses the leucine zipper motif of AF10 onto the HRX gene. Blood 1995; 86: 2073–2076.
  CAS PubMed Google Scholar
• Thirman MJ, Levitan DA, Kobayashi H, Simon MC, Rowley JD . Cloning of ELL, a gene that fuses to MLL in a t(11;19)(q23;p13.1) in acute myeloid leukemia. Proc Natl Acad Sci USA 1994; 91: 12110–12114.
  Article CAS PubMed PubMed Central Google Scholar
• Rubnitz JE, Morrissey J, Savage PA, Cleary M . ENL, the gene fused with HRX in t(11;19) leukemias, encodes a nuclear protein with transcriptional activation potential in lymphoid and myeloid cells. Blood 1994; 84: 1747–1752.
  CAS PubMed Google Scholar
• Schichman SA, Caligiuri MA, Gu Y, Strout MP, Canaani E, Bloomfield CD et al. ALL-1 partial duplication in acute leukemia. Proc Natl Acad Sci USA 1994; 91: 6236–6239.
  Article CAS PubMed PubMed Central Google Scholar
• Caligiuri MA, Strout MP, Lawrence D, Arthur DC, Baer MR, Yu F et al. Rearrangement of ALL1 (MLL) in acute myeloid leukemia with normal cytogenetics. Cancer Res 1998; 58: 55–59.
  CAS PubMed Google Scholar
• Archimbaud E, Charrin C, Magaud JP, Campos L, Thomas X, Fiere D et al. Clinical and biological characteristics of adult de novo and secondary acute myeloid leukemia with balanced 11q23 chromosomal anomaly or MLL gene rearrangement compared to cases with unbalanced 11q23 anomaly: confirmation of the existence of different entities with 11q23 breakpoint. Leukemia 1998; 12: 25–33.
  Article CAS PubMed Google Scholar
• Mathew S, Behm F, Dalton J, Raimondi S . Comparison of cytogenetics, Southern blotting, and fluorescence in situ hybridization as methods for detecting MLL gene rearrangements in children with acute leukemia and with 11q23 abnormalities. Leukemia 1999; 13: 1713–1720.
  Article CAS PubMed Google Scholar
• Yamamoto K, Seto M, Lida S, Komatsu H, Kamada N, Kojima S et al. A reverse transcriptase-polymerase chain reaction detects heterogeneous chimeric mRNAs in leukemias with 11q23 abnormalities. Blood 1994; 83: 2912–2921.
  CAS PubMed Google Scholar
• Schoch C, Schnittger S, Klaus M, Kern W, Hiddemann W, Haferlach T . AML with 11q23/MLL abnormalities as defined by the WHO classification: incidence, partner chromosomes, FAB subtype, age distribution, and prognostic impact in an unselected series of 1897 cytogenetically analyzed AML cases. Blood 2003; 102: 2395–2402.
  Article CAS PubMed Google Scholar
• Bower M, Parry P, Carter M, Lillington DM, Amess J, Lister TA et al. Prevalence and clinical correlations of MLL gene rearrangements in AML-M4/5. Blood 1994; 84: 3776–3780.
  CAS PubMed Google Scholar
• Poirel H, Rack K, Delabesse E, Radford-Weiss I, Troussard X, Debert C et al. Incidence and characterization of MLL gene (11q23) rearrangements in acute myeloid leukemia M1 and M5. Blood 1996; 87: 2496–2505.
  CAS PubMed Google Scholar
• So CW, Ma ZG, Price CM, Dong S, Chen SJ, Gu LJ et al. Wiedemann LM. Chan LC. MLL self fusion mediated by Alu repeat homologous recombination and prognosis of AML-M4/M5 subtypes. Cancer Res 1997; 57: 117–122.
  CAS PubMed Google Scholar
• Watanabe N, Kobayashi H, Ichiji O, Yoshida MA, Kikuta A, Komada Y et al. Cryptic insertion and translocation or nondividing leukemic cells disclosed by FISH analysis in infant acute leukemia with discrepant molecular and cytogenetic findings. Leukemia 2003; 17: 876–882.
  Article CAS PubMed Google Scholar
• Tanaka K, Eguchi M, Eguchi-Ishimae M, Hasegawa A, Ohgami A, Kikuchi M et al. Restricted chromosome breakpoint sites on 11q22–q23.1 and 11q25 in various hematological malignancies without MLL/ALL-1 gene rearrangement. Cancer Genet Cytogenet 2001; 124: 27–35.
  Article CAS PubMed Google Scholar
• Giugliano E, Rege-Cambrin G, Scaravaglio P, Wlodarska I, Emanuel B, Stul M et al. Two new translocations involving the 11q23 region map outside the MLL locus in myeloid leukemias. Haematologica 2002; 87: 1014–1020.
  CAS PubMed Google Scholar
• Cox MC, Panetta P, Lo-Coco F, Del Poeta G, Venditti A, Maurillo L et al. Chromosomal aberration of the 11q23 locus in acute leukemia and frequency of MLL gene translocation: results in 378 adult patients. Am J Clin Pathol 2004; 122: 298–306.
  Article CAS PubMed Google Scholar
• Shih LY, Huang CF, Wu JH, Lin TL, Dunn P, Wang PN et al. Internal tandem duplication of FLT3 in relapsed acute myeloid leukemia: a comparative analysis of bone marrow samples from 108 adult patients at diagnosis and relapse. Blood 2002; 100: 2387–2392.
  Article CAS PubMed Google Scholar
• Liang DC, Shih LY, Yang CP, Hung IJ, Chen SH, Liu HC . Molecular analysis of fusion transcripts in childhood acute myeloid leukemia in Taiwan. Med Pediatr Oncol 2001; 37: 555–556.
  Article CAS PubMed Google Scholar
• Liang DC, Shih LY, Hung IJ, Yang CP, Chen SH, Jaing TH et al. Clinical relevance of internal tandem duplication of the FLT3 gene in childhood acute myeloid leukemia. Cancer 2002; 94: 3292–3298.
  Article CAS PubMed Google Scholar
• Rubnitz JE, Behm FG, Curcio-Brint AM, Pinheiro RP, Carroll AJ, Raimondi SC et al. Molecular analysis of t(11;19) breakpoints in childhood acute leukemias. Blood 1996; 87: 4804–4808.
  CAS PubMed Google Scholar
• Repp R, Borkhardt A, Haupt E, Kreuder J, Brettreich S, Hammermann J et al. Detection of four different 11q23 chromosomal abnormalities by multiplex-PCR and fluorescence-based automatic DNA-fragment analysis. Leukemia 1995; 9: 210–215.
  CAS PubMed Google Scholar
• Tse W, Zhu W, Chen HS, Cohen A . A novel gene, AF1q, fused to MLL in t(1;11) (q21;q23), is specifically expressed in leukemic and immature hematopoietic cells. Blood 1995; 85: 650–656.
  CAS PubMed Google Scholar
• Megonigal MD, Cheung NK, Rappaport EF, Nowell PC, Wilson RB, Jones DH et al. Detection of leukemia-associated MLL-GAS7 translocation early during chemotherapy with DNA topoisomerase II inhibitors. Proc Natl Acad Sci USA 2000; 97: 2814–2819.
  Article CAS PubMed PubMed Central Google Scholar
• Fu JF, Hsu JJ, Tang TC, Shih LY . Identification of CBL, a proto-oncogene at 11q23.3, as a novel MLL fusion partner in a patient with de novo acute myeloid leukemia. Genes Chromosomes Cancer 2003; 37: 214–219.
  Article CAS PubMed Google Scholar
• Fu JF, Liang DC, Yang CP, Hsu JJ, Shih LY . Molecular analysis of t(X;11)(q24;q23) in an infant with AML-M4. Genes Chromosomes Cancer 2003; 38: 253–259.
  Article CAS PubMed Google Scholar
• Vardiman JW, Harris NL, Brunning RD . The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 2002; 100: 2292–2302.
  Article CAS PubMed Google Scholar
• Byrd JC, Mrozek K, Dodge RK, Carroll AJ, Edwards CG, Arthur DC et al. Cancer and Leukemia Group B (CALGB 8461). Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461). Blood 2002; 100: 4325–4336.
  Article CAS PubMed Google Scholar
• Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, Harrison G et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood 1998; 92: 2322–2333.
  CAS PubMed Google Scholar
• Grimwade D, Walker H, Harrison G, Oliver F, Chatters S, Harrison CJ et al. Medical Research Council Adult Leukemia Working Party. The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial. Blood 2001; 98: 1312–1320.
  Article CAS PubMed Google Scholar
• Slovak ML, Kopecky KJ, Cassileth PA, Harrington DH, Theil KS, Mohamed A et al. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study. Blood 2000; 96: 4075–4083.
  CAS PubMed Google Scholar
• Mrozek K, Heinonen K, Lawrence D, Carroll AJ, Koduru RPK, Rao KW et al. Adult patients with de novo acute myeloid leukemia and t(9;11)(p22;q23) have a superior outcome to patients with other translocations involving band 11q23: a cancer and leukemia group B study. Blood 1997; 90: 4532–4538.
  CAS PubMed Google Scholar
• Martinez-Climent JA, Lane NJ, Rubin CM, Morgan E, Johnstone HS, Mick R et al. Clinical and prognostic significance of chromosomal abnormalities in childhood acute myeloid leukemia de novo. Leukemia 1995; 9: 95–101.
  CAS PubMed Google Scholar
• Raimondi SC, Chang MN, Ravindranath Y, Behm FG, Gresik MV, Steuber CP et al. Chromosomal abnormalities in 478 children with acute myeloid leukemia: clinical characteristics and treatment outcome in a cooperative pediatric oncology group study-POG 8821. Blood 1999; 94: 3707–3716.
  CAS PubMed Google Scholar
• Rubnitz JE, Raimondi SC, Tong X, Srivastava DK, Razzouk BI, Shurtleff SA et al. Favorable impact of the t(9;11) in childhood acute myeloid leukemia. J Clin Oncol 2002; 20: 2302–2309.
  Article CAS PubMed Google Scholar
• Osaka M, Rowley JD, Zeleznik-Le NJ . MSF (MLL septin-like fusion), a fusion partner gene of MLL, in a therapy-related acute myeloid leukemia with a t(11;17)(q23;q25). Proc Natl Acad Sci USA 1999; 96: 6428–6433.
  Article CAS PubMed PubMed Central Google Scholar
• Ono R, Taki T, Taketani T, Taniwaki M, Kobayashi H, Hayashi Y . LCX, leukemia-associated protein with a CXXC domain, is fused to MLL in acute myeloid leukemia with trilineage dysplasia having t(10;11)(q22;q23). Cancer Res 2002; 62: 4075–4080.
  CAS PubMed Google Scholar
• Kourlas PJ, Strout MP, Becknell B, Veronese ML, Croce CM, Theil KS et al. Identification of a gene at 11q23 encoding a guanine nucleotide exchange factor: evidence for its fusion with MLL in acute myeloid leukemia. Proc Natl Acad Sci USA 2000; 97: 2145–2150.
  Article CAS PubMed PubMed Central Google Scholar
• Schnittger S, Kinkelin U, Schoch C, Heinecke A, Haase D, Haferlach T et al. Screening for MLL tandem duplication in 387 unselected patients with AML identify a prognostically unfavorable subset of AML. Leukemia 2000; 14: 796–804.
  Article CAS PubMed Google Scholar
• Steudel C, Wermke M, Schaich M, Schakel U, Illmer T, Ehninger G et al. Comparative analysis of MLL partial tandem duplication and FLT3 internal tandem duplication mutations in 956 adult patients with acute myeloid leukemia. Genes Chromosomes Cancer 2003; 37: 237–251.
  Article CAS PubMed Google Scholar
• Döhner K, Tobis K, Ulrich R, Frohling S, Benner A, Schlenk RF et al. Prognostic significance of partial tandem duplications of the MLL gene in adult patients 16–60 years old with acute myeloid leukemia and normal cytogenetics: a study of the Acute Myeloid Leukemia Study Group Ulm. J Clin Oncol 2002; 20: 3254–3261.
  Article PubMed Google Scholar
• Yu M, Honoki K, Andersen J, Paietta E, Nam DK, Yunis JJ . MLL tandem duplication and multiple splicing in adult acute myeloid leukemia with normal karyotype. Leukemia 1996; 10: 774–780.
  CAS PubMed Google Scholar